Transition Therapeutics Inc Stock

Stocks

16-08-25	Transition Therapeutics : Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Arrangement with OPKO Health, Inc.	PR
16-06-03	Transition Therapeutics : Receives Notification From NASDAQ	PR
16-05-11	Transition Therapeutics : Announces Third Quarter Fiscal 2016 Financial Results	PR
16-05-09	Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST	PR
16-04-18	Transition Therapeutics : Provides Update on Type 2 Diabetes Drug Candidate TT401	PR

1 day

+0.52%

Manager	Title	Age	Since
Antonio F. Cruz CEO	Chief Executive Officer	73	1998-07-05

Director	Title	Age	Since
Antonio F. Cruz CHM	Chairman	73	2010-08-03

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TRANSITION THERAPEUTICS INC	+0.52%	-6.31%	-	-	0
MODERNA, INC.	-0.80%	+28.07%	+705.55%	+98.39%	79.4B
REGENERON PHARMACEUTICALS, INC.	-4.54%	-4.15%	+33.40%	-9.65%	78.69B
CSL LIMITED	+2.80%	+3.60%	-6.34%	-27.82%	59.52B
UCB	-0.89%	+2.11%	+7.92%	+170.43%	46.58B
SAMSUNG BIOLOGICS CO.,LTD.	+2.49%	+0.14%	-8.95%	+33.71%	46.53B
BIOGEN INC.	+0.48%	+6.12%	+66.48%	-11.20%	33.63B
INCYTE CORPORATION	+0.75%	-0.39%	+50.93%	+111.17%	25.11B
INNOVENT BIOLOGICS, INC.	-3.56%	-0.47%	+3.11%	+135.37%	22.13B
SWEDISH ORPHAN BIOVITRUM AB	+0.73%	-1.70%	+61.19%	+100.64%	15.31B
Average	-0.12%	+4.30%	+101.48%	+66.78%	45.21B
Weighted average by Cap.	-0.36%	+6.71%	+154.20%	+53.71%

Employees

Sector